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1INTRODUCTION
Coronary artery calcification (CAC) is noticed in the early
atherosclerotic lesions that appear in the second and third decades of
life, but it is more often found in the advanced atherosclerotic lesions
and in older age.
Coronary arterial calcification is a change occurring almost
exclusively in atherosclerotic arteries, and is absent in the normal vessel
wall. Hence the presence of any CAC is nearly 100% specific for
atheromatous coronary plaque. Since both obstructive and non-
obstructive lesions can have calcification present in the intima, CAC is
not specific for obstructive coronary disease.
The  site  and  the  amount  of  coronary  artery  calcium  and  the
percent  of  coronary  luminal  narrowing  at  the  same  anatomic  site,  the
relation is nonlinear and has large confidence limits. As the occurrence
of calcification reflects an advanced stage of plaque development, some
researchers have proposed that the correlation between coronary
calcification and acute coronary events may be suboptimal based largely
on angiographic series5.
2In order to understand this apparent conflict between the stability
of a calcified lesion and CHD event rates, one must recognize the
association between atherosclerotic plaque extent and more frequent
calcified and non-calcified plaque6.
Atherosclerotic Hardening of the Artery
showing Plaque with Calcification
1. Intima 2. Media 3. Adventitia
.
3That is, patients who have calcified plaque are also more likely to
have non-calcified or "soft" plaque that is prone to rupture and acute
coronary thrombosis 6.
PATHOPHYSIOLOGY OF CORONARY CALCIFICATION
Calcification of atherosclerotic plaque occurs by means of an
active process resembling the bone formation under the control of
complex cellular pathways. A large number of invitro studies have
highlighted the importance of calcium in the process of vascular
calcification of osteoblast like cells, cytokines, transcription factors, and
bone morphogenic proteins found in the normal bone.
Calcification of the intima is characterized by cellular apoptosis,
inflammation, lipoprotein, phospholipid accumulation, and finally
hydoxyapatite deposition. Calcification is first noticed in the lipid core
of the atheroma juxtaposed to the inflammatory cells that infiltrate the
fibrocalcific plaque.
The basic mechanism initiating the process of calcification is
unknown, but it seems to require apoptosis of intralesional cells, likely
the smooth muscle cells. The apoptotic bodies would then work as
nucleating foci of calcification.
4a. The CAC score is age and gender specific and therefore there has
to be a comparison of the individual data to a normal cohort in
order to produce a meaningful data, usually presented as the
percentile distribution. In general, CAC develops 10 to 15years
later in life in women than in men. Similarly CAC is generally 5
to 7 times lower at any given age in women than in men.
b.  In patients at intermediate clinical risk for coronary events the
CAC score can help to reclassify patients to a higher or lower risk
group.  For  instance  a  CAC  score  of  zero  confirms  low  risk  of
events.  Conversely a CAC score of  greater  than 400 is  observed
with a significant cardiac event rate in patients who appear to be
intermediate risk by Framingham score.
c.  More common in men, diabetics and renal failure pts.
d.  The role of CAC scoring in determining risk in patients with CKD
and/or ESRD is unclear due to a limited number of clinical studies
in these populations.
Some studies suggest that patients with CKD and ESRD develop
calcification in the tunica media layer of the arterial wall, unlike the
typical intimal calcification that is known to be associated with plaque
5burden. The role of medial calcification as a marker of cardiovascular
risk is not well defined. Some studies reveal an association between
coronary calcium and prevalent cardiovascular disease in patients
undergoing  dialysis  and  coronary  calcium score  is  associated  with  risk
for total mortality19 .
Figure 1-1 showing normal cardiac anatomy as depicted by
contrast-enhanced multidetector computed tomography
6A,Level of the ascending aorta (Ao) andpulmonary artery, usually the
topmost level of a cardiac CT image data set.
B, Level of the left main coronary artery (LM), which can be seen
originating from the aortic root and dividing into the left anterior
descending coronary artery and left circumflex coronary artery (arrow).
C, Level of the proximal right coronary artery (RCA).
D, Midventricular level.
E, Level of the caudal right atrium. The drainage of the coronary sinus
into the right atrium (RA) can be seen.
F, Level of the distal right coronary artery.
G, Multiplanar reconstruction to create a short axis view.
H, Multiplanar reconstruction to create a four-chamber view.
I, Three-dimensional surface reconstruction, shown from an anterior
view. The coronary arteries can be recognized on the surface of the
heart.
CS = coronary sinus; Dg = diagonal branch; IVC = inferior vena cava;
LA = left atrium; LAA = left atrial appendage; LAD = left anterior
descending coronary artery; LCX = left circumflex coronary artery;
LV = left ventricle, OM = obtuse marginal branch; Pc =pericardium;
PA  =  pulmonary  artery;  RA  =  right  atrium;  RV  =  right  ventricle;
RVOT = right ventricular outflow tract; SVC = superior vena cava.
7Analysis of Coronary Artery Calcium
Multi-detector computed tomography (MDCT) and Electron-
beam computed tomography (EBCT) are the primary fast CT methods
for CAC measurement at this time. Both technologies employ thin slice
CT imaging, using fast scan speeds to reduce motion artifact.
30 to 40 adjacent axial scans usually are obtained. A calcium
scoring system has been devised based on the X-ray attenuation
coefficient or CT number measured in Hounsfield units and the area of
calcium deposits. A fast CT study for coronary artery calcium
measurement requires only a few seconds of scanning time and the
whole study is completed within 10 to 15 minutes.
Cardiac computed tomography has been used with increasing
frequency in the United States and other countries during the past 15
years, initially with the goal of identifying patients at risk of having
obstructive coronary artery disease based on the amount of coronary
calcium present.
However, in the past 5 to 10 years, fast CT methods have been
used primarily for 2 purposes:
81) To assist in coronary heart disease (CHD) risk assessment in
asymptomatic patients, and
2) To assess the likelihood of the presence of CHD in patients who
present  with  atypical  symptoms  which  could  be  consistent  with
myocardial ischemia.
Table 1 -1 showing significance of age and CAC score.17
AGE IN
YEARS
CAC
SCORE
SENSITIVITY
(%)
SPECIFICITY
(%)
NEGATIVE
PREDICTIVE
VALUE FOR
ZERO SCORE (%)
40 to 49 50 71 91 98
50 to 59 50 74 70 94
60 to 69 300 74 81 100
Agatston Coronary Artery Calcium Scoring system:
The Agatston coronary calcium volume score is the most
frequently used scoring system. It is a Area/Step method which takes
into account the area of the calcified lesion and the maximum CT value
within the lesion. It is derived by measuring the area of each calcified
coronary lesion and multiplying it by a coefficient of 1 to 4, depending
on the maximum CT attenuation within that lesion. It is important to
9realize the reproducibility of the Agatston score before applying the
recommended guidelines for cut points. Importantly the variability in
score has very little meaning at the very high and very low scores. Inter-
reader variability can be as high as 3%17.
Table 1-2 Agatston method (Area/Step Method)
CT number
Equal to or greater than Less than
Coefficient
(Step/Weight factor)
Threshold 200 1
200 300 2
300 400 3
400 4
Score for ROI = (Step/Weight factor) x (the area of the lesion)
(The calculated score is normalized to slice thickness of 3mm)
The CAC score can be classified in to five groups.
1)  0 - No coronary calcification
2)  Upto 99 - Mild coronary calcification
3)  100 to 399 - Moderate calcification
4)  400 to 999 - Severe calcification
5)  >1000 - Extensive calcification.
10
Other methods of calculating Calcium score
Mass score
It is possibly the most definitive method for quantifying calcium
within a lesion. The method is based on calculating the mean CT
number of a calcification and multiplying the result by the volume of the
calcification and a calibration factor to obtain the calcification mass.
This is expressed as mi = cCTivi
? mi – Calcification mass
? vi – Lesion area above the defined threshold (in mm2) x distance
between the reconstructed slice (in mm)
? c – Calibration factor (included in the software)
Continuous weight factor method (based on lesion volume)
In this scoring method, which is based on spiral CT data
acquisition, the volume and the weighting factor are continuous.
The lesion volume is obtained by multiplying the area (in mm2)
that is above the threshold with the distance between the reconstructed
slices (in mm). This provides a score on a volumetric basis (in mm3).
The continuous weight factor (Wc), for calcified lesions above the
threshold, is calculated by the formula: Wc = (CT-50)/100
The Volumetric score is calculated as follows:
Score = (Wc) x (the lesion volume)
11
Detection of Coronary Artery Calcification
The standard imaging protocol is to acquire 40 consecutive 3-mm
thick images at a rate of 100 ms per image from the base of the heart to
just below the carina. Images are obtained at end-inspiration, with ECG
triggering typically at 80 percent of the R-R interval (end-diastole).
Image pixel size using a 512 x 512 reconstruction matrix is 0.26 or 0.34
mm2 based on a 26- or 30-cm field of vision, respectively.
A calcified lesion is generally defined as either two or three
adjacent pixels (0.68 to 1.02 mm2 for a 5122 reconstruction matrix and
camera field size of 30 cm) of >130 Hounsfield units (HUs). Using the
traditional Agatston method, each calcified lesion is multiplied by a
density factor as follows: 1 for lesions with a maximal density between
130 and 199 HU; 2 for lesions between 200 and 299 HU; 3 for lesions
between 300 and 399 HU; and 4 for lesions >400 HU.
The total coronary artery calcium score (CACS) is calculated as
the sum of each calcified lesion in the four main coronary arteries over
all the consecutive tomographic slices. The EBCT-derived CACS
correlates well with calcified areas found in individual coronary arteries
as determined by histomorphometric measurements (r=0.96,
p <0.0001)16.
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MULTIROW DETECTOR COMPUTED TOMOGRAPHY:
Advancements in CT technology have improved image
acquisition speed and patient throughput. Multidetector computed
tomography (MDCT) scanners produce images by rotating an x-ray tube
around a circular gantry through which the patient advances on a
moving couch. Increased numbers of detectors have allowed much faster
throughput, essentially reducing the time to image the entire cardiac
anatomy to less than 10 seconds.
The introduction of multirow spiral CT detector systems (i.e.,
Multislice CT) currently allow acquisition of 4 to 64 simultaneous
images, with slice thickness reduced to 0.5 to 0.625 mm. Improvements
in gantry rotation speeds and the development of partial reconstruction
algorithms have reduced effective single-image acquisition time to <200
msec.
However, image acquisition within 50 ms is required to
completely avoid cardiac motion artifacts. The coronary arteries also
move independently throughout the cardiac cycle and even at slow heart
rates (i.e., <70 beats/min) exhibit significant translational motion of up
to 60 mm/sec for the right coronary artery (RCA) and 20 to 40 mm/sec
for the left anterior descending (LAD) and circumflex coronary
arteries44.
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Retrospective gating with MDCT employs acquisition of multiple
images throughout each cardiac cycle. With multirow detector CT
systems, temporal resolution may be further improved by selecting
specific partial image sector data from different heartbeats and detector
rings to reconstruct a complete 240-degree image data set. With
retrospective gating, several hundred images can be acquired during a
single  cardiac  study,  allowing  one  to pick and choose images with the
least amount of motion-related distortion prior to final image
reconstruction. With a temporal resolution of 250 msec per image, this
method presently is most effective for patients with a heart rate of less
than 70 beats per minute. The high spatial resolution, the low image
noise, and the high tissue contrast are superior to those of any other
imaging technique. However, this oversampling leads to significant
excess radiation exposure to the patient.
The typical radiation exposure from an electron-beam computed
tomography (EBCT) study is <1.0 rad, whereas MDCT scanners using
retrospective gating can increase exposure approximately 13-fold.44
Prospective gating during either spiral or nonspiral acquisitions
employs image triggering only at a specific temporal location of the
cardiac cycle, thereby significantly reducing radiation exposure. Gating
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works relatively well at slow heart rates (i.e., <60 beats/min), where the
R-R interval is >1000 ms and the fastest imaging protocols are used.
However, at faster heart rates, a 200-msec acquisition, effectively covers
most of the cardiac cycle, thus obviating any potential benefit from
gating the image acquisition.
MDCT imaging protocols vary among different camera systems
and manufacturers. Generally 40 consecutive 2.5- to 3-mm-thick images
are acquired per cardiac study. Calcified lesions are defined as two or
three adjacent pixels with a tomographic density of either >90 or >130
HU. Effective pixel size for a reconstruction matrix of 512 x 512 pixels
with a common field of view of 26 cm is 0.26 mm2. Calcium scoring is
usually based on the traditional Agatston method (i.e., initial density of
>130 HU). The total CACS is calculated as the sum of each calcified
plaque over all the tomographic slices.
Multirow Detector Computed Tomography compared to Electron
Beam Computed Tomography:
The comparability of MDCT- and EBCT-derived coronary artery
calcium scores has been explored in separate studies involving
approximately 400 patients.17–19 The MDCT protocols vary considerably
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in these studies, ranging from conventional CT to single-slice CT (with
either retrospective or prospective gating) to multislice CT .
EBCT imaging was performed using the standard protocol
conventionally used in routine clinical practice. Coronary calcification
was defined as >130 HU for EBCT but varied from 90 to 130 HU for
MDCT. Although high correlation coefficients were reported between
EBCT and MDCT CACS, there was significant variability in individual
CACS results (range 17 to 84 percent).
Table 1-3 EBCT versus Mechanical CT
Author Year
Number
of
Patients
Age
Average
Ca2+
Score
Mechanical
CT
Technique
Gating
Number
of
Detectors
Correlation
Coeffecient
Mean %
Difference
Becker20 1999 50 61 983 Nonspiral No Single 0.98 42%
Budoff17 2001 33 54 52 Nonspiral No Single 0.68 84%
Knez19 2002 99 60 722 Spiral Prosp 4 0.99 17%
Ca2+, calcium; CT, computed tomography; EBCT, electron-beam computed tomography; prosp, prospective.
aAgatston score except as indicated. bVolumetric score.
A more recent study by Knez and coworkers compared MDCT to
EBCT using prospective ECG gating for both techniques.19 The CACS
was calculated using the volumetric (rather than the Agatston) calcium
scoring method.
Variability in CACS between the two techniques ranged from 20
percent (CACS <100) to 15 percent (CACS >100), with a mean
16
variability of 17 percent. Further research is still needed to determine
which MDCT technique, imaging protocol, calcium criterion, and
scoring system best approximates the values determined by EBCT,
especially with the new 64-detector systems. No calcium data is yet
available from these state of the art scanners.
Coronary Artery Calcification and Atherosclerotic Plaque burden:
The presence of CAC is clearly indicative of coronary
atherosclerosis.25,26. Furthermore, the CACS severity, as assessed by
EBCT, is directly related to the total atherosclerotic plaque burden
present in the epicardial coronary arteries.25,26 Coronary calcification is
thought to begin early in life, but it progresses more rapidly in older
individuals who have further advanced atherosclerotic lesions.27
Calcification is an active, organized, and regulated process
occurring during atherosclerotic plaque development where calcium
phosphate in the form of hydroxyapatite precipitates in atherosclerotic
coronary arteries in a similar fashion as observed in bone
mineralization.28–30 Although lack of calcification does not categorically
exclude the presence of atherosclerotic plaque, calcification occurs
exclusively in atherosclerotic arteries and is not found in normal
coronary arteries.
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Table 1-4 showing accuracy of Coronary Artery Calcification in
Detecting Significant (>50%) Coronary Artery Stenosis as defined
by Angiography
Investigator Year
Number
of
Subjects
Sensitivity(%) Specificity(%)
Positive
Predictive
Accuracy
Negative
Predictive
Accuracy
Agatston17 1990 584 96 51 31 98
Budoff43 1996 710 95 44 72 84
Detrano19 1996 491 95 31 51 89
Baumgart36 1997 57 97 21 56 86
Schmermund3 1997 118 95 88 99 58
The presence and extent of histologically determined plaque area
has been compared to the total calcium area as assessed by EBCT in
individual coronary arteries derived from autopsied hearts.25 A  strong
linear correlation exists between total coronary artery plaque area and
the extent of CAC as found in individual hearts (r = 0.93, p < 0.001) and
in individual coronary arteries (r = 0.90, p < 0.001). However, the total
calcium area underestimates total plaque area, with approximately five
times as many noncalcified as calcified plaques.25
Coronary Artery Calcification and Stenosis severity:
Significant (>50 percent) coronary artery stenosis by angiography
is almost universally associated with the presence of coronary artery
18
calcium as assessed by EBCT. However, the severity of angiographic
coronary  artery  stenosis  is  not  directly  related  to  the  total  CACS.  A
recent study compared calcium extent to coronary artery luminal
diameter stenosis determined by morphologic examination of 723
coronary artery segments.26
Although coronary stenosis severity increased with increasing
CAC, this relationship was poor and could not be used to estimate
angiographic stenosis severity on a segment-by-segment basis. One
explanation is that coronary artery remodeling occurs with increasing
plaque burden so as to maintain luminal diameter and arterial patency.31
Although the extent of coronary calcification does not precisely predict
stenosis severity, noncalcified plaques are almost universally associated
with <50 percent diameter stenosis and typically <20 percent stenosis.26
These data indicate that lack of coronary calcification predicts a very
low likelihood of obstructive CAD.
Clinical angiographic trials confirm the relationship between
CACS  severity  and  the  presence  of  significant  (50  percent)  CAD.32
Although the diagnostic accuracy of EBCT improves with age, most
patients younger than 50 years with obstructive CAD also have coronary
calcification (85 percent).33, To date there are 15 studies evaluating
19
EBCT with coronary angiography in which obstructive CAD was
defined as >50 percent luminal diameter stenosis32
In these studies, the overall sensitivity and specificity for
detecting obstructive CAD were 97 and 39 percent, respectively. In the
largest series, Haberl and colleagues performed EBCT within 30 days of
coronary angiography in 1764 patients who had suspected CAD.41 Only
5 of 940 patients (0.5 percent) with significant (50 percent) coronary
artery stenosis had a normal EBCT, and four of these were younger than
45 years of age. Although differences in CACS were noted among men
and women, EBCT predicted CAD equally well in both genders, based
on age-specific CACS thresholds.41 Coronary artery calcification (CAC)
assessment may also be useful for detecting CAD in heart transplant
recipients.4
The poor specificity of coronary calcium scanning can be
reconciled by the fact that the coronary calcification confirms the
presence of atherosclerotic plaque but it may not necessarily be
obstructive. The CACS severity may be a better barometer of
obstructive CAD than the mere presence of calcium.
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Budoff and coworkers observed that specificity increased with the
number of calcified coronary arteries (i.e., high calcium scores).33 Two
separate reports in patients referred for coronary angiography found that
a CACS >100 best predicted obstructive CAD with an equally high
sensitivity and specificity of 80 percent.
There appears to be a threshold CACS above which most patients
will have significant coronary artery stenosis. The accuracy for
identifying significant CAD based on CACS may be further improved
by incorporating age, gender,39 and traditional risk-factor information.
However, despite the relationship between obstructive CAD and CACS
severity, the latter is still too imprecise in itself to be used as a definitive
criterion for proceeding directly to coronary angiography.
The current American College of Cardiology/American Heart
Association (ACC/AHA) guidelines on coronary angiography do not
recommend coronary angiography on the basis of a positive EBCT but
do suggest angiography may be avoided with the finding of a negative
(zero score) study
21
Prognosis by Coronary Artery Calcium Measurements:
In the prior ACC/AHA expert consensus document published in
2000, only 3 reports on the prognostic capability of CAC scoring were
available to develop risk assessment indications in asymptomatic
individuals. At the time, the ACC/AHA document concluded that the
body of evidence using CAC measurement to predict CHD events was
insufficient7.
A  critical  component  to  that  recommendation  was  that  the
independent prognostic value of CAC had not been established. In a
separate but similar evaluation using data published through 2002, the
U.S. Preventive Services Task Force (USPSTF) concluded that limited
clinical outcomes data were available and recommended against routine
screening for the detection of silent but severe CAD or for the prediction
of CHD events in low risk, asymptomatic adults.
In the past several years, however, a number of publications have
reported on the incremental prognostic value of CAC in large series of
patients including asymptomatic self-referred and population cohort.
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A major rationale for the current document is the need for an
update including recent publications regarding CAC as it relates to the
estimation of CHD death or nonfatal myocardial infarction (MI).
Although earlier evidence included the use of "soft" endpoints
including coronary revascularization as a primary outcome, more recent
data are available on the estimation of CHD death or MI. Models
predicting "hard" cardiac events (i.e., CHD death or MI) are less
subjective and less likely to overestimate the predictive accuracy of
CAC scoring.
Other Uses:
1.  To differentiate between ischemic and non ischemic
cardiomyopathy. One large study in 120 patients with heart
failure of unknown etiology demonstrated the presence of CAC
was associated with 99% sensitivity for ischemic
cardiomyopathy. Another study also demonstrated similarly high
sensitivity using fast CT to differentiate ischemic from non-
ischemic cardiomyopathy 11
2.  To triage chest pain patients in Emergency Department.
23
3.  Presence of any calcium – There is a fourfold risk of coronary
events in the next 3 to 5 years.
4.  To reclassify intermediate risk group to either low or high risk
group based on Framingham risk score. The accumulating
evidence suggests that asymptomatic individuals with an
intermediate FRS may be reasonable candidates for CHD testing
using CAC as a potential means of modifying risk prediction and
altering therapy. On the other hand, there is little to be gained by
testing  with  CAC  in  patients  with  a  low  FRS.  Furthermore,
patients with a high FRS should be treated aggressively consistent
with secondary prevention goals based upon the current NCEP III
guidelines and thus should not require additional testing,
including CAC scoring, to establish this risk evaluation 13.
5.  Statins has no effect on CAC progression if score is more than
100.
24
AIM OF THE STUDY
? To compare Agatston CAC (coronary artery calcium) score in
patients with Obstructive and Non obstructive CAD.
? To compare Agatston CAC score in patients with single and
multivessel disease.
? To compare Agatston CAC score in males and females.
? To compare Agatston CAC score in those with and without HT,
Smoking and Diabetes.
? To compare Agatston CAC score between Infarct related artery
and other vessels in multivessel disease.
25
REVIEW OF LITERATURE
Theoretical relationship between Coronary Calcification and CHD
events:
There are conflicting results regarding the site, extent of coronary
artery calcification and the angiographic grading based on various
available data. Atherosclerotic plaque proceeds through progressive
stages where instability and rupture can be followed by calcification,
perhaps to provide stability to an unstable lesion.
As the occurrence of calcification reflects an advanced stage of
plaque development, some researchers have proposed that the
correlation between coronary calcification and acute coronary events
may be suboptimal based largely on angiographic series.
There is no known relationship between vulnerable plaque and
coronary artery calcification3. The relation of arterial calcification, like
that of angiographic coronary artery stenosis, to the probability of
plaque rupture is unknown4.
Although radiographically detected coronary artery calcium can
provide an estimate of total coronary plaque burden, due to arterial
26
remodeling, calcium does not concentrate exclusively at sites with
severe coronary artery stenosis 5.
It is the co-occurrence of calcified and non-calcified plaque that
provides the means for estimating acute coronary events. Furthermore,
although CAC detection cannot localize a stenotic lesion or one that is
prone to rupture, CAC scoring may be able to globally define a patient’s
CHD event risk by virtue of its strong association with total coronary
atherosclerotic disease burden, as shown by correlation with pathologic
lesions.
The Committee judged that it may be reasonable to consider use
of CAC measurement in such patients based on available evidence that
demonstrates incremental risk prediction information in this selected
(intermediate risk) patient group. This conclusion is based on the
possibility that such patients might be reclassified to a higher risk status
based on high CAC score, and subsequent patient management may be
modified9.
In order to understand this apparent conflict between the stability
of a calcified lesion and CHD event rates, one must recognize the
association between atherosclerotic plaque extent and more frequent
27
calcified and noncalcified plaque. That is, patients who have calcified
plaque are also more likely to have non-calcified or "soft" plaque that is
prone to rupture and acute coronary thrombosis.
A subset analysis of the predictive accuracy of CAC in patients
with an intermediate FRS reveals that for a score greater than or equal to
400, the patient’s 10-year CHD risk would achieve risk equivalent status
similar to that noted with diabetes or peripheral arterial disease. Thus,
clinical decision-making could potentially be altered by CAC
measurement in patients initially judged to be at intermediate risk (10%
to 20% in 10 years) 12.
Most unexpected cardiovascular events occur in persons at
intermediate risk of coronary artery disease (10%–20% 10-year risk).
The absence of CAC by cardiac CT is associated with a low adverse
event risk and therefore could be used as a tool to counsel patients about
their risk of such events13.
Coronary artery scanning using electron beam computed
tomography is a diagnostic tool with application to high-risk and
symptomatic subjects that can assist in diagnosing or excluding
coronary artery disease. Although there is ample evidence for the utility
28
of this and related technologies for diagnosis in symptomatic subjects,
this remains an unproven technology for screening healthy
asymptomatic subjects1
Multiple logistic regression analysis determined male sex,
presence of diabetes and left anterior descending (LAD) and circumflex
(LCX) coronary calcium scores, independent from more distal calcium
localization, as independent predictors for identification of three-vessel
and/or left main CAD2.
On the basis of a simple algorithm ("noninvasive index"), EBCT
calcium scanning in conjunction with risk factor analysis can rule in or
rule out angiographically severe disease, i.e., three-vessel and or left
main CAD, in symptomatic patients2.
On average, significant coronary disease (greater than 50% or
greater than 70% stenosis by coronary angiography) was reported in
57.2% of the patients. Presence of CAC was reported on average in
65.8% of patients (defined as a score greater than 0 in all but one report)
Higher coronary calcium scores increased the likelihood of
detecting significant coronary disease (greater than 50% or greater than
70% luminal stenosis). A threshold of detectable calcium or a score
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greater than 5 was associated with an odds of significant disease of 25.6
fold (95% CI 9.6 to 68.4)1.
Because of its potential in this regard, further research should be
encouraged to determine its place in the armamentarium of diagnostic
tools. In contrast to its unproven utility for screening asymptomatic
populations, electron beam computed tomographic coronary calcium has
shown fairly accurate association with coronary angiographic findings in
symptomatic patients referred for angiography for chest pain
syndromes1.
MESA STUDY - The Multi Ethnic Study of Atherosclerosis
(6800 subjects) has reported that all modern Multi Detector Row CT
systems are at least as reliable as EBCT for performing and reproducing
coronary calcium measurements 1.
From the ST. FRANCIS HEART STUDY, measured risk factor
data were available in 1293 of the total enrolled cohort of 4903
asymptomatic individuals. In univariable (p less than 0.0001) and
multivariable (p = 0.01) models estimating CHD events at 4.3 years of
follow-up, CAC scores were independently predictive of CHD outcome
above and beyond both historical and measured risk factors37.
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RECALL STUDY- The Heinz-Nixdorf Risk factors Evaluation of
Coronary Calcium, and Lifestyle study (4200 subjects) provides
unbiased information on the extent of coronary calcium in the general
German population from a suburban community3.
In this study again the coronary calcium score was superior to
conventional risk factors for predicting coronary heart disease. This was
true even for all four major racial and ethnic groups in the
United States1.
Coronary atherosclerotic changes may appear calcified,
noncalcified or mixed plaque lesion. Noncalcified lesions are found
predominantly in patients who have AMI, whereas calcified lesions are
found more often in patients who have chronic stable angina 14.
The CT density of noncalcified plaques is significantly lower in
the culprit coronary segment of patients studied at the time of acute
coronary syndromes as compared with those who have chronic stable
disease15. In patients who have an acute coronary syndrome, a
noncalcified lesion in the coronary artery may correspond to an
intracoronary thrombus16.
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The current gold standard to detect coronary atherosclerosis in
vivo is intravascular ultrasound (IVUS).studies comparing IVUS with
multidetector row CT (MDCT) have shown a good correlation between
the echogenicity by IVUS and the CT density of coronary
atherosclerotic lesions.
The sensitivity and specificity for CT to detect calcified and non
calcified coronary atherosclerosis are 78% and 94%, respectively the
sensitivity to comparison between CTA and IVUS is only 52%.
However, probably because of the lower spatial resolution if CTA 18.
O’Rourke, et al study is a meta-analysis of various studies which
asses the diagnostic or prognostic accuracy of coronary artery calcium.
Patients with nonobstructive coronary disease are defined by a stenosis
of 50% or 20%. Varying stenotic lesion cut points were used. The
weighted-average (by sample size) sensitivity and specificity were
80.4% and 39.9%, respectively, whereas specificity values ranged from
21% to 100%. Predictive accuracy (ie, percent correct classification)
ranged from 41% to 95%. Significant coronary calcium scores had a
higher accuracy in detecting disease with stenosis >50%.  Because this
study was conducted in a symptomatic population with an angiographic
end point, its application is limited to such patients.
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Coronary Artery Calcification: Prognostic Implications
The likelihood of plaque rupture and the development of acute
cardiovascular events are related to the total atherosclerotic plaque
burden.27 Although controversy exists as to whether calcified or
noncalcified plaques are more prone to rupture28 extensive calcification
indicates the presence of both plaque morphologies.7
There is a direct relationship between the CACS severity, the
extent of atherosclerotic plaque, and the presence of silent myocardial
ischemia. Many studies have now demonstrated an increased risk for
cardiac events in asymptomatic patients who have extensive silent
myocardial ischemia 29. Therefore, the CACS could be useful for risk
assessment of asymptomatic individuals and potentially guide
therapeutics.
Several recent trials in both symptomatic and asymptomatic13
patients have studied whether the extent of CAC as assessed by EBCT
can predict subsequent patient outcome. In 422 symptomatic patients
followed for 30 ± 12 months 29 cardiac events were 10-fold higher in
patients with a CACS above the 75th percentile for age (9.5 percent)
versus those below the 25th percentile (0.9 percent). Another study of
288 symptomatic patients referred for coronary angiography30 showed
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that patients with a CACS >100 had a 3.2-fold higher relative risk of
death or MI than those with a lower CACS (95 percent confidence limit:
1.17–8.71).
In the longest study of EBCT scanning of the coronary arteries,
the SOUTH BAY HEART WATCH STUDY, 1196 asymptomatic
patients were followed (median = 7.0 years) and it was demonstrated
that the CACS score added predictive power beyond that of standard
coronary risk factors and C reactive protein.31
Among 1173 asymptomatic patients followed for 3.6 years after
an initial screening EBCT,32 no events occurred in patients with a
normal study and the negative predictive value was 99.8 percent in
patients with a CACS <100. These results show a 5, 7, and 13 percent
hard cardiac event rate in individuals with a CACS 80, 160, and 600,
respectively.32 The CACS remained the best single predictor of risk after
adjustment. Wong and colleagues also showed that the CACS severity
predicted subsequent events independent of age, gender, and patient
risk-factor profile33.
Raggi and coworkers reported on 172 patients who had EBCT
within 60 days of an unheralded MI and on 632 asymptomatic patients
who were referred for a screening EBCT and then followed for 32 ± 7
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months.34 Ninety-six percent of all patients with infarction were
abnormal by EBCT, and the CACS was 100 in 62 percent and 400 in 47
percent of patients.
Table 3-1 Multivariate Analyses of the Association of Coronary
Artery Calcium Scores and Self-Reported Traditional Coronary
Disease Risk Factors with All Eventsa
Variable Odds Ratio (95% CI)
Elevated cholesterol 3.9 (1.3–11.7)
Hypertension 2.8 (1.2–6.5)Independent of CACS
Diabetes 5.4 (2.0–14.9)
CACS >80 14.3 (4.9–42.3)
Age >55 y 3.3 (1.3–8.4)
Elevated cholesterol 4.0 (1.3–12.2)
Hypertension 2.6 (1.1–6.1)
With CACS 80
Diabetes 4.8 (1.6–13.9)
CACS >160 19.7 (6.9–56.4)
Age >55 y 4.5 (1.6–12.2)
Elevated cholesterol 3.7 (1.2–11.5)
Hypertension 3.0 (1.2–7.4)
With CACS 160
Diabetes 5.8 (2.1–19.7)
CACS >600 20.2 (7.3–55.8)
Age >55 y 2.9 (1.1–7.9)
Elevated cholesterol 3.5 (1.1–10.8)
Hypertension 2.9 (1.2–7.3)
With CACS 600
Diabetes 4.4 (1.4–13.7)
CI, confidence interval; aAnalysis were performed with and without the
coronary artery calcium scores (CACS)32.
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Both the absolute CACS and the relative CACS percentiles
adjusted for age and gender predicted subsequent death and nonfatal MI.
Hard cardiac events occurred in only 0.3 percent of subjects with a
normal EBCT, but this increased to 13 percent in those with a CACS
>400. A very high CACS 1000 may portend a particularly high risk of
death or MI (i.e., 25 percent per year).35
Larger trials have been reported, demonstrating approximately
10-fold increased risk with the presence of CAC.36 in one of the largest
observational trials to date.
Shaw and colleagues reported all-cause mortality among 10,377
asymptomatic patients (4191 women and 6186 men) who had a baseline
EBCT and were then followed for 5.0 ± 3.5 years.38 Most subjects had
cardiac risk factors including a family history of CAD (69 percent),
hyperlipidemia (62 percent), hypertension (44 percent), and current
cigarette smoking (40 percent). The CACS was a strong independent
predictor of mortality (x2 = 36.6, p < 0.00001) with 43 percent
additional predictive value contained within the CACS beyond risk
factors alone. Mortality significantly increased with increasing CACS.
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Similarly, in a younger cohort of asymptomatic persons35 the  3
year mean follow up in 2000 participants (mean age 43 years) showed
that coronary calcium was associated with an 11.8-fold increased risk
for incident coronary heart disease (CHD) (p < 0.002) in a Cox model
controlling for the Framingham risk score.
The ROTTERDAM HEART STUDY39 investigated 1795
asymptomatic participants (mean age 71 years) who had CAC and
measured risk factors. During a mean follow up of 3.3 years, the
multivariate-adjusted relative risk of coronary events was 3.1 (95
percent CI, 1.2–7.9) for calcium scores of 101 to 400, 4.6 (95 percent
CI, 1.8–11.8) for calcium scores of 401 to 1000, and 8.3 (95 percent
CI, 3.3–21.1) for calcium scores >1000 compared with calcium scores
of  0 to 100.
The COOPER CLINIC STUDY40 included 10,746 adults who
were 22 to 96 years of age and free of known CHD. During a mean
follow up of 3.5 years, 81 hard events (CHD death, nonfatal MI)
occurred. Age-adjusted rates (per 1000 person years) of hard events
were computed according to four CAC categories: no detectable CAC
and incremental sex-specific thirds of detectable CAC; these rates were,
respectively, 0.4, 1.5, 4.8, and 8.7 (trend p < 0.0001) for men and 0.7,
2.3, 3.1, and 6.3 (trend p < 0.02) for women.
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The association between CAC and CHD events remained
significant after adjustment for CHD risk factors. A Munich Study
determined the extent of CAC by MDCT in 924 patients (443 men, 481
women, aged 59.4 ± 18.7 years).
During the 3-year follow-up period, the event rates for coronary
revascularization (5.4 %/y vs. 2.9 %/y), MI (3.8 %/y vs. 1.8 %/y), and
cardiac death (2.1 %/y vs. 1.0 %/y) in patients with volume scores above
the 75th percentile were significantly higher compared to the total study
group and no cardiovascular events occurred in patients with scores of
zero. Receiver operating characteristic (ROC) analysis demonstrated it
outperformed both PROCAM and Framingham models (p < 0.0001),
where 36 percent and 34 percent of MIs occurred in the high risk
cohorts, respectively.
Coronary artery calcium score in diabetes population.
A study demonstrated the risk stratification in uncomplicated type
2 diabetes in a prospective evaluation of CAC and MPS.42 Risk factors
and CAC scores were prospectively measured in 510 asymptomatic type
2 diabetic subjects (mean age 53 ± 8 years, 61 percent males) without
prior cardiovascular disease with a median follow up of 2.2 years. In the
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multivariable model, the CAC score and extent of myocardial ischemia
were the only independent predictors of outcome (p < 0.0001).
ROC analysis demonstrated that CAC predicted cardiovascular
events with the best area under the curve (0.92), significantly better than
the United Kingdom Prospective Diabetes Study Risk Score (0.74) and
Framingham Score (0.60, p < 0.0001). The relative risk to predict a
cardiovascular event for a CAC score of 101 to 400 was 10.13, and
increased to 58.05 for scores >1000 (p < 0.0001). No cardiac events or
perfusion abnormalities occurred in subjects with CAC 10 Agatston
units up until 2 years of follow up.
The CAC score appears to provide complementary prognostic
information to that obtained by the Framingham risk model. Combining
EBCT results with biochemical markers, such as C-reactive protein,
may more precisely define risk than either test alone. . More data is
needed in different ethnic groups prior to widespread application.41
Calcium Score and Ethinicity
Finally data from the MESA study1 and other series demonstrated
that whites have a higher prevalence of CAC and CAC scores than the
other races, and this raised the question of the validity of CAC in non-
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whites .Two recent publications addressed the value of CAC as a marker
of risk in four different races (White, African American, Chinese and
Hispanic) in the united states .
Nasir and his colleagues evaluated the use of CAC to predict all
cause mortality (505 deaths during the 10 years follow up) in 14,812
patients .the prevalence of CAC was higher in whites, although blacks
and Hispanics had a greater clustering of risk factors for CAD.
Despite a low prevalence of CAC and lower scores compared
with other races, black patients demonstrated the highest mortality rates
even after multivariable adjustment for clinical risk factors and baselines
CAC scores (p,<.0001).compared with whites the relative risk for death
was 2.97 (95%cl:1.87-4.72) in blacks ,1.58 (95%cl:0. 92-2.71) in
Hispanics and 0.85 (95% cl:0.47-1.54) in Chinese.
Detrano and his colleagues1 showed that CAC is a strong
predictor of CVD, non fatal myocardial infarction, angina and
revascularization independent of race in 6722 MESA patients (the risk
increased 7.7 fold in patients with a CAC score between 101 and 300
compared with 0 and 9.7 fold in patients with a score >300).
Furthermore CAC added incremental prognostic value beyond
traditional risk factors for prediction of all events in all races.
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Hence, CAC seems to be an excellent marker of risk in all races
so far investigated although the prognostic significance of score
categories may vary among the racial groups.
The evidence surrounding the CAC was recently reviewed into
two statements of the American Heart Association12 and the American
College Of Cardiology, which recognized the potential utility of CAC
screening for refinement of risk assessment in intermediate risk peoples.
MATERIALS AND METHODS.
? This study was conducted in the Barnard Institute of Radiology,
Government General Hospital, Chennai, during the year 2008 –
2010.
? The study is a prospective observational non interventional study
involving 100 patients diagnosed with STEMI and after the
treatment at the Department of Cardiology, Government General
Hospital, Chennai.
? Ethical committee clearance was obtained to conduct the study in our
hospital.
? All subjects provided written informed consent in their own
language to participate in the study before inclusion.
Inclusion Criteria:
? All patients following STEMI (MI diagnosed by History, ECG.
ECHO & Enzymes) including both recent and old myocardial
infarction irrespective of age and sex.
? Both thrombolysed & not thrombolysed patients.
? Patients with or without LV dysfunction.
Exclusion Criteria
? All acute coronary syndrome patients.
? All chronic stable angina patients.
? Chronic kidney disease.
? Uncontrolled tachycardia.
? Technically inadequate CT.

Study Centre
? Barnard Institute of Radiology – Government General Hospital,
Chennai – 3.
? Single centre, Prospective Observational, Non-interventional study.
? Detailed history was obtained from all the patients, including the
presence of risk factors like
- Diabetes mellitus,
- Hypertension,
- Smoking and
- Family history of ischemic heart disease.
? Baseline investigations were done in all patients including complete
blood count, blood sugar, renal function tests, lipid profile, chest X-
ray. ECG, ECHO, Cardiac enzymes, namely, Creatinine kinase and
CK-MB were done in all patients.
Patient characteristics:
The study population included 100 patients (91 males and 9 females)
who had were admitted to the Department of Cardiology, Govt. Genseral
Hospital, Chennai – 3, for coronary angiography evaluation following
STEMI.
Table 4-1 Showing Patient Characteristics:
Group 1
(n=50)
Group 2
(n=50) TOTAL
Positive CAC 26 19 45
Negative CAC 24 31 55
Age < 40 years 7 10 17 (17%)
40 to 60 years 11 5 16 (16%)
>60 years 32 35 67 (67%)
Male 46 45 91 (91%)
Female 4 5 9 (9%)
Hypertension 15 10 25 (25%)
Diabetes 8 13 31 (31%)
Smoking 16 5 21 (21%)
F/H of CAD 4 1 5 (5%)
Our study population contains predominantly male (90%). One
fourth of the population had hypertension and one third of the study group
are diabetics. One fifth are smokers. Only few patients gave history of
smoking.
Figure 4-1 Agatston Score in
Obstructive CAD
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Figure 4-2 Agatston Score in
Non obstructive CAD
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Table 4-2 Classification of Total CAC score
Total CAC Score Classification Group I Group II
0 No Calcification 24 31
Upto 99 Mild Calcification 10 11
100 – 399 Moderate Calcification 10 3
400 - 999 Severe Calcification 6 4
> 1000 Extensive Calcification 0 1
Group I – Obstructive CAD, Group II – Nonobstructive CAD
Coronary Angiography:
? All patients following STEMI admitted to undergo coronary
angiography (After an average period of 4 to 6 weeks following
STEMI) in the department of cardiology underwent CAG by a team
of expert cardiologists using Philips Integri 3000 machine.
Government General Hospital, Chennai-3.
? CAG was done through both the femoral and radial route, using
properly sized sheath, Judkin’s catheter, Amplatz catheter and Tiger
catheters if necessary. Multiple angulations and views were used.
The CAG was analyzed and the lesions are quantified in detail.
Lumen diameter narrowing was graded as 0, 25,50,75,90 and 100%.
A detail report with pictures are prepared and tabulated.
Complications:
Five patients of the study group developed minor complications in
the form of minor hematoma, transient benign arrhythmias. There is no
death, MI or CVA in the study group following the procedure.
Based on CAG findings the study population is categorized into
study Group I– With obstructive CAD (defined as >50% luminal
obstruction irrespective of the infarct related artery) and Group II – With
non obstructive CAD (<50% luminal obstruction in any of the epicardial
coronaries as well as normal coronaries).
Agatston score measurements:
Then the patients were referred to Barnard Institute of Radiology,
Government General Hospital, Chennai-3 for assessment of CAC score.
(Average waiting period for CAC measurement following CAG is 2
weeks).
It was done using Philips Brilliance 64 slice MDCT machine based
on Agatston scoring system with no knowledge about the CAG lesions of
the patients concerned.
Image 4-1 Philips Brilliance 64 slice MDCT machine
Image 4-2 Philips Extended Brilliance Workspace
Scoring Procedure
The Philips Extended Brilliance Workspace was used to calculate the
calcium score by Agatston method. It is an independent diagnostic viewing
and processing workstation. A Dell computer running Windows XP,
software version 3.5 is used.
The Cardiac Score of each ROI in each image depends on the Area
with CT values greater than the threshold and on the density of CT values
in that region. A total score is calculated for the selected sequence of
images by selecting a preset, or user defined, scoring method.
The appropriate series must be gated axial or helical scan and must
be a single volume. Areas of pixel values above the threshold are marked in
pink (by default). To increase the accuracy of the procedure, the selected
scoring images can be enlarged by choosing a screen format of one or four.
The zoom function can be display only the area of interest in the screen
frames.
The images selected for scoring must be from the same series, with
equal spacing between them, and whose slice thickness is equal to or
greater than the spacing. Since the scoring process provides quantitative
results, all images from the region being scored must be selected, not just
those images with visible calcifications.
Image 4-3 Seeding by automatic method
Image 4-4 Scoring results by Agatston scoring protocol
ROI can be created by a manual tool or by automatic tool. The
manual tool provides a variety of shapes to manually draw the ROI. The
automatic tool allows us to create ROI using a single click. The seed tools
are used to define the ROI. The seeding can be done for specific vessels by
selecting before seeding. The system automatically identifies the calcified
area, changes the color of the area, and adds it to the score calculation. The
automatic tool is used for all the patients in our study.
The scoring results are displayed in the screen with Score, ROIs and
Area (sq mm) against the individual vessels along with the total score. The
score in the individual vessels and the total score are tabulated in the study.
The Extended Brilliance Workspace provides Agatston database to
relate the individual patient score to an asymptomatic population score. A
percentile value is presented which places the patient score in comparison
to the asymptomatic population score. However these percentiles are not
used in our study.
Any score greater than zero is considered as positive score based on
Agatston scoring system. And the results of both groups who underwent
CAC scores were tabulated, compared and analyzed in detail.
RESULTS
Statistical analysis:
The results were analyzed by the following statistical methods.
1)  Chi-square test
2)  Mann Whitney U Wilcox on Rank Sum test
3)  Correlation coefficient methods
4)  Multiple regression analysis.
The p values are categorized as follows.
a)  0 to 0.01 - Significant at 1% level.
b)  0.01 to 0.05- Significant at 5% level.
c)  > 0.05 - No statistical significance.
Figure 5-1 Data comparison graph
Figure 5-2 Multiple line graph
Table 5-1 Summary statistics table
Obstructive CAD Nonobstructive CAD
N 50 50
Mean 105.9 94.5
95% CI 23.6 – 188.2 51.0 – 137.9
Variance 83947.6 23409.5
SD 289.7 153.0
RSD 2.7 1.6
Median 0.0 2.5
95% CI 0.0 – 5.9 0.0 – 29.3
Table 5-2 Correlation coefficient
Variable Y Obstructive CAD
Variable X Non obstructive CAD
Sample size 50
Correlation coefficient r 0.03132
Significance level P = 0.8290
95% Confidence interval for r -0.2492 to 0.3070
Table 5-3 showing Sensitivity, Specificity, Predictive values and
Likelihood ratios in detecting Agatston score in Group I in
comparison to group II
Obstructive
CAD
Nonobstructive
CAD
Total
CAC
present
26 19 45
CAC absent 24 31 55
50 50 100
Sensitivity 52.00%
Specificity 62.00%
Positive likelihood Ratio 1.37
Negative likelihood Ratio 0.77
Disease Prevalence 50.00%
Positive Predictive Value 57.78%
Negative Predictive Value 56.36%
The study showed poor sensitivity, specificity, predictive values
and likelihood ratios in detecting Agatston score in Obstructive CAD in
comparison to Nonobstructive CAD. The p values show no statistical
significance.
Table 5-4 showing patient’s CAG baseline profile in Group I :
VESSEL
INVOLVEMENT
LAD
LCX
RCA
LAD
LCX
RCA
LAD
LCX
RCA
LAD
&
LCX
LAD
&
RCA
LCX
&
RCA
LAD,
LCX
&
RCA
NO OF CASES
12 3 5 7 14 2 7
Table 5-5 showing Types of MI and the vessels involved.
VESSELS
INVOLVED
AWMI IWMI / RVMI
LAD 13 1
LCX 0 3
RCA 2 3
LAD & LCX 4 1
LCX & RCA 3 4
LAD & RCA 6 2
LAD,LCX & RCA 6 1
About 90% of AWMI patients showed LAD involvement whereas LCX
& RCA are the predominant culprit vessels among patients with
IWMI/RVMI.
Table 5-6 showing the significance of risk factor and CAC scores in
patients in Group I:
S.No Variable
Positive
CAC
Negative
CAC
p
value
Significance
1 DIABETES 9 3 0.067 SIGNIFICANT
2 HYPERTENSION 8 7 0.901
NOT
SIGNIFICANT
3 SMOKING 11 5 0.103
NOT
SIGNIFICANT
4 FAMILY
HISTORY
4 0 0.045 SIGNIFICANT
5 SEX
M-24, F-
2
M-21,
F-3
0.571
NOT
SIGNIFICANT
6 AGE MEAN
50.82
MEAN
48.84
0.025 SIGNIFICANT
The above analysis are done using chi-square test regarding the
significance of the above variable and total CAC score among GROUP
1 patients.
It showed that though the conventional risk factors like
hypertension, smoking and male sex are associated with increased CAC
scores they are not statistically significant whereas the diabetes, age and
positive family history is predictive of increased CAC scores in patients
with obstructive CAD and it is statistically significant.
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Figure 5-3 showing risk factor and CAC
correlation in GROUP I patients.
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Figure 5-4 showing risk factor and CAC
correlation in GROUP II patients.
Positive CAC Negative CAC
Table 5-7 showing the significance of risk factor and CAC scores in
patients in Group II:
S.No Variable
Positive
CAC
Negative
CAC
P
value
Significance
1 DIABETES 5 3 0.119
NOT
SIGNIFICANT
2 HYPERTENSION 1 9 0.041 SIGNIFICANT
3 SMOKING 2 3 0.922
NOT
SIGNIFICANT
4
FAMILY
HISTORY
1 0 0.196
NOT
SIGNIFICANT
5 SEX
M - 17,
F- 2
M – 29,
F - 2
0.606
NOT
SIGNIFICANT
6 AGE
MEAN
-  52.84
MEAN -
49.12
0.072 SIGNIFICANT
The above analysis is done using chi- square test regarding the
significance of the above variable and total CAC score among GROUP
II patients.
It showed that though the conventional risk factors like diabetes,
smoking, family history and male sex are associated with increased
CAC scores they are not statistically significant except age which has
good correlation with statistical significance. It was also found that
history of hypertension shows negative predictive value for CAC scores
in patients with non obstructive CAG and it is statistically significant
(p- 0.041).
Table 5-8 showing the significance of individual vessel involvement
and CAC scores in patients in Group I
CAC LAD LCX RCA TOTAL P VALUE
LAD
0.1545
P=0.284
0.0258
P=0.859
0.0161
P=0.912
0.1128
P=0.436
NOT
SIGINIFICANT
LCX
0.0038
P=
0.979
0.1617
P=0.289
0.1529
P=0.289
0.0298
P=0.837
NOT
SIGINIFICANTCAG
RCA
0.0893
P=
0.538
0.075
P =
0.605
0.1718
P =
0.233
0.1663
P
=0.248
NOT
SIGINIFICANT
A detailed analysis of CAG lesions of individual vessel was
correlated with the CAC score of the corresponding vessel of patients
among obstructive CAD. The above details of Group 1 comparing CAG
with CAC score were analyzed using the correlation coefficient method
and the details revealed no statistical significance. Thus it shows that
there is no correlation between the stenosis and the CAC score of the
vessel involved.
Table 5-9 showing the significance of individual vessel involvement
and CAC scores in patients in Group II.
S.NO
LAD
CAC
LCX
CAC
RCA
CAC
TOTAL
CAC
P VALUE
1
LAD
CAG
0.0598
P=0.68
0.0599
P=0.68
0.761
P=0.6
0.0739
P=0.61
NOT
SIGINIFICANT
2
LCX
CAG
0.0038
P=
0.979
0.1617
P=0.289
0.1529
P=0.289
0.0439
P=0.762
NOT
SIGINIFICANT
3
RCA
CAG
0.0893
P=
0.538
0.075
P =
0.605
0.1718
P =
0.233
0.1204
P
=0.405
NOT
SIGINIFICANT
A detailed analysis of CAG lesions of individual vessel was
correlated with the CAC scores of corresponding vessel in patients
among Non obstructive CAD. The above details of Group II comparing
CAG with CAC score were analyzed using the correlation coefficient
method and the details revealed no statistical significance. Thus it shows
that there is no correlation between the CAG stenosis and the CAC score
of the vessel involved among patients with Non obstructive CAD.
Table 5-10 showing the significance of multivessel involvement and
CAC scores in patients in both groups.
S.NO
VESSELS
INVOLVED
MULTIPLE R SIGNIFICANCE
1 LAD & LCX 0.112 NO
2 LAD & RCA 0.245 NO
3 LCX & RCA 0.166 NO
4 LAD, LCX & RCA 0.250 NO
The significance of correlation of multivessel involvement and
total calcium scoring was analyzed by multiple regression analysis. The
CAC score was analyzed between double and triple vessel involvement
with single vessel disease. It was found that there is no increase in either
the positivity or the degree of CAC score with multivessel involvement
when compared to single vessel disease.
DISCUSSION
Our study showed poor sensitivity, specificity, predictive values
and likelihood ratios in using Agatston score to differentiate Obstructive
CAD from Nonobstructive CAD. The p values show no statistical
significance.
O’Rourke,et al study is a meta-analysis of various studies which
asses the diagnostic or prognostic accuracy of coronary artery calcium.
Patients with nonobstructive coronary disease are defined by a stenosis
of 50% or 20%. Varying stenotic lesion cut points were used. The
weighted-average (by sample size) sensitivity and specificity were
80.4% and 39.9%, respectively, whereas specificity values ranged from
21% to 100%. Predictive accuracy (ie, percent correct classification)
ranged from 41% to 95%. Significant coronary calcium scores had a
higher accuracy in detecting disease with stenosis >50%.  Because this
study was conducted in a symptomatic population with an angiographic
end point, its application is limited to such patients.
Our study showed that though the conventional risk factors like
hypertension, smoking and male sex are associated with increased CAC
scores, they are not statistically significant whereas the diabetes, age and
positive family history is predictive of increased CAC scores in patients
with obstructive CAD and it is statistically significant.
Further it was also found that though the conventional risk factors
like diabetes, smoking, family history and male sex are associated with
increased CAC scores they are not statistically significant except age
which has good correlation and history of hypertension shows negative
predictive value for CAC scores in patients with non obstructive CAG
and it is statistically significant.
CAC Scores and Gender:
Gender differences in utility and accuracy of imaging tests are
typically related to differences in the epidemiology of coronary heart
disease, with women having later onset of clinical CHD than men.
Gender differences in incidence and prevalence of CAD are most
marked in middle-aged populations, the typical target age group for
CHD screening. In addition, emerging data suggest that there may be
actual gender differences in the anatomy of atherosclerosis.
Thus, it is important to consider gender-specific data when
evaluating the potential uses of any new cardiac test. There are limited
data broadly specific to women on the relationship between CHD
outcomes and CAC. Existing data confirm an association between CAC
scores and all-cause mortality and CHD events in elderly women.
The Prospective Army Coronary Calcium (PACC) Project19
found a higher prevalence of coronary calcium in white (19.2%) than
black (10.3%) active-duty military personnel with a mean age of 42
years; the difference persisted after adjusting for cardiovascular disease
risk factors.
Budoff et al. described similar findings in white men referred for
CAC testing compared with black men; however, in this study, black
women had a higher prevalence of coronary calcium than white women.
In addition, Asian men and women had a lower prevalence of coronary
calcium, and the prevalence in Hispanics was similar to the whites20
The utility of CAC screening has also been investigated in special
subsets of populations such as women, diabetic patients and elderly
.Two original investigations and one meta analysis supported the utility
of CAC for risk stratification in women. The authors’ group11 compared
the occurrence of all-death in approximately 4000 women and 6000 men
referred for CAC screening by primary vary physicians.
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I with CAC score.
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Figure 6-2 showing Sex distribution in Group
II with CAC score.
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CAC scores were lower in women than in the men (p<.001), but
death rates were higher among the older, diabetic, hypertensive and
smoking patients of both the gender. In risk adjusted models; women
had a greater probability of death than the men for the CAC score
importantly. CAC score added incremental prognostic value to the FRS
(p<.0001) in both the genders.
Lakoski and colleagues conducted gender analyses of the Multi
Ethnic Study of Atherosclerosis (MESA) data and noted that a CAC
score greater than 0 was strong predictor of coronary heart and CVD
events in 2684 women considered to be at low risk by Framingham
categories compared with patients without CAC (hazard ratios 6.5and
5.2 respectively) finally in a meta-analysis of three prospective and two
observational registries. Bellasi and his colleagues concluded that CAC
screening is equally accurate in stratifying risk for all-cause death and
CVD events in women and in men.
There are only limited no of female patients involved in our study
because of social reasons as many of our female patients are not willing
to enroll in our study. In our study there are only 4 female in Group I
and 5 female in Group II. There is no positive correlation of CAC score
in males compared to females in both groups.
Smoking:
A strong dose–response relationship between cigarette smoking
and CHD has been observed in both sexes, in the young, in the elderly,
and in all racial groups.11 Cigarette smoking increases risk two- to
threefold and interacts with other risk factors to multiply risk. There is
no evidence that filters or other modifications of the cigarette reduce
risk. Pipe smoking and cigar smoking increase the risk of CHD. More
than 1 in every 10 cardiovascular deaths in the world in the year 2000
was attributable to smoking.25
Smoking does not carry a significant risk for coronary
calcification as compared to international studies .There were 16
patients (32%) in group I and 5 (10%) patients in group II with smoking
history. But in both groups smoking does not show a statistically
significant correlation of increased CAC score. ( p – 0.103 in Group I:
P-0.922 in Group II)
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and CACS in both groups.
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Calcium Score in the Elderly:
Age is an important predictive factor for coronary artery
calcification in our study independent of CAG lesions. Several recent
cohorts have been published including prospective observational
registries in predominantly male, younger and middle-aged , unselected
and older-aged, higher risk asymptomatic cohorts8 .
For age group 40 to 49 and 50 to 59 years, a total score of 50
resulted in a sensitivity of 71% and 74% and a specificity of 91% and
70%, respectively. For age group 50 to 59 years, a total score of 300
gave a sensitivity of 74% and a specificity of 81%.
CAC maintains its utility for risk stratification in the elderly. In
the prospective Rotterdam study, 2013 participants (mean age: 71+_5.7
years) received CAC screening and measurement of traditional
cardiovascular risk factors23.
Men and women in the highest CAC score category showed an
adjusted odd ratio for myocardial infarction of 7.7 (95%cl:4.1-14.5) and
6.7 (95%cl:2.4-19.1 ), respectively, compared with the lowest score
category (0-100). The predictive power of CAC was independent of
FRS category (low, intermediate or high).
Raggi and colleagues followed 35,388 patients, with 3570
subjects being 70 years of age or older at screening, for an average
period of 5.8+_3 years .The author ‘s group11 reported an expected
increase in all cause mortality rate with increasing age. (relative hazard
per age decline increase =1.09,95% cl;1.08-1.10 ;p<.0001).
With higher death rates among men than women nonetheless,
increasing CAC score were associated with decreasing survival rates
across all age declines ( p<.0001) suggesting that CAC is evident even
in the elderly. Finally using CAC score categories, more than 40% of
elderly patients were reclassified into lower or higher risk categories
compared with their original FRS group.
In our study the mean age is 50.82 in Group I and showed a
significant association with increased CAC score with statistical
significance. (P- 0.025)
In Group II the mean age of the population 50.82 and showed a
significant association with increased CAC score with statistical
significance (P- 0.006). And this matches with the above mentioned
various international studies.
Calcium Score in Diabetic patients:
Several clinical studies have shown that glucose intolerance and
insulin resistance are associated with increased prevalence of CAC.
Similarly frank diabetes is associated with a greater risk of CAC
compared with those in non-diabetic population .Wong and colleagues
and Anand and colleagues22 demonstrated an increasing incidence of
inducible ischemia on stress myocardial perfusion imaging in diabetic
patients with a greater amount of CAC.
Type 2 diabetic patients with a CAC score of 10 or less, 11 to100,
101 to 400, 401 to 1000, and greater than 1000 had an incidence of
myocardial ischemia of 0%, 18%, 23%, 48%, 71% respectively, and
morbidity and mortality increased proportionally with CAC score and
ischemic burden in an observational registry.
Raggi and his colleagues showed a higher all-cause mortality rate
for any extent of CAC for diabetic subjects than the non-diabetic
patients (p >0.0001). Of interest the 5- year mortality rate of diabetic
patients with little or no CAC (approximately 30% cohort of 903
diabetic patients ) was as low as that of nondiabetic subjects without
CAC (approximately 1% at the end of the follow up).13
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History with CACS in both groups.
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It is not an important predictive factor for coronary artery
calcification in our study independent of CAG lesions. However, Raggi
et al. found that coronary calcium predicted all-cause mortality in
diabetics referred for fast coronary CT scanning.
Raggi et al. also found that patients with diabetes have a greater
increase in risk for mortality associated with a given degree of calcium
than the non-diabetic patients. Diabetic patients without any evidence of
coronary calcification have a survival rate similar to non-diabetic
patients with a zero calcium score during 5 years of follow-up.
These results suggest that coronary calcium might be useful to
further stratify short-term risk in diabetic patients. However, until
studies from non-referral populations with longer follow-up, including
fatal and non-fatal cardiovascular events are completed, CAC scores
should not be used to modify treatment goals in diabetic patients.
In Group I there are 12 diabetics (24%) with 9 cases (18%)
showing positive CAC and 3 cases (6%) showing negative CAC with a
good statistical significance. Hence diabetes showed a significant
association with CAC in patients with obstructive CAD with statistical
significance (P- 0.06)
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Figure 6-8 showing no of AWMI and
IWMI/RVMI cases in both groups
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In Group II there are 10 diabetics (20%) with 7 (14%) cases
showing positive CAC and 3 (6%) cases showing negative CAC with no
statistical association. Hence diabetes showed no significant association
with CAC in patients with non obstructive CAD (P- 0.11). And this
matches in certain aspects with the above mentioned various
international studies
CAC Score and Multivessel involvement:
The CAC score was analyzed by multiple regression analysis
between double and triple vessel involvement with that of single vessel
disease. It was found that there is no increase in either the positivity or
the degree of CAC score with multivessel involvement when compared
to single vessel disease.
Incidental findings in patients undergoing CAC Testing:
Coronary calcium measurement by fast CT scanning of the heart
includes imaging of a portion of the lungs, mediastinum, bones and
upper abdomen, in addition to the aorta.
The identification of potential pathology other than coronary
calcium must be considered when evaluating the benefits and costs of
cardiac CT scanning. The most common incidental finding is pulmonary
nodules9 but in our study we found few aortic, pulmonary artery and
pulmonary vein calcification.
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CONCLUSION
1) Sixty four slice MDCT derived Agatston score is a useful tool to
assess angiographic severity in Post MI population.
2) Agatston score shows poor correlation in differentiating the
obstructive and nonobstructive coronary artery disease following
STEMI.
3) Agatston scores showed good correlation in patients with
obstructive CAD especially in Elderly, Diabetics and in those
with a family history of CAD.
4) There is less correlation of Agatston score with regards to other
conventional risk factors like Gender, Hypertension and Smoking
in both obstructive and non obstructive CAD.
5) Agatston score was not useful to identity infarct related artery.
6) There was no linear correlation between Agatston score and the
number of vessel involvement.
7) There was a significant negative correlation in hypertensive
patients among non obstructive CAD population.
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LIMITATIONS OF THE STUDY
1)  There are only limited no of female patients involved in our study
as many of our female patients were not willing to undergo
coronary angiogram.
2)  IVUS which is the gold standard is not performed to study the
extent of accurate plaque burden for comparison.
3)  CAC scores in patients with renal disease could not be studied as
there is risk in CAG regarding contrast usage.
4)  We have not followed the patients in long term for analysis
regarding the prognostic implications of CAC scores.
5)  CAC score is not analyzed in patients with acute coronary
syndrome and chronic stable angina.
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GLOSSARY AND ACRONYMS
AMI- Acute Myocardial Infarction.
AWMI- Anterior Wall Myocardial Infarction.
IWMI- Inferior Wall Myocardial Infarction.
RVMI- Right Ventricular Myocardial Infarction.
LWMI- Lateral Wall Myocardial Infarction.
CAD- Coronary Artery Disease.
CAC-coronary artery calcium.
LAD- left anterior descending artery.
LCX- left circumflex artery.
RCA- right coronary artery.
OM-obtuse marginal, D-diagonal artery.
STEMI- ST segment Elevation Myocardial Infarction.
LVEF- Left Ventricular Ejection Fraction.
EBCT- Electron Beam Computed Tomography.
MDCT- Multirow Detector Computed Tomography.
MRI-Magnetic Resonance Imaging.
ECG- Electrocardiogram.
ECHO- Echocardiogram.



